Quantitative Structure-cytotoxicity Relationship of 3-Benzylidenechromanones

Yoshihiro Uesawa1, Hiroshi Sakagami2, Hajime Kagaya3

  • 1Department of Clinical Pharmaceutics, Meiji Pharmaceutical University, Kiyose, Japan uesawa@my-pharm.ac.jp.

Anticancer Research
|October 30, 2016
PubMed
Abstract

Insights

Quantitative structure-activity relationship (QSAR) analysis of 3-benzylidenechromanones revealed that molecular shape and polarization are key for tumor-specificity. Certain derivatives showed higher tumor-specificity than doxorubicin and 5-fluorouracil.

Area of Science:

  • Medicinal Chemistry
  • Computational Chemistry
  • Pharmacology

Background:

  • 3-Benzylidenechromanones are investigated for potential anticancer activities.
  • Understanding structure-activity relationships is crucial for developing targeted cancer therapies.
  • Cytotoxicity and tumor-specificity are key parameters for evaluating anticancer drug candidates.

Purpose of the Study:

  • To perform a quantitative structure-activity relationship (QSAR) analysis on 3-benzylidenechromanones.
  • To evaluate the cytotoxicity and tumor-specificity of these compounds against oral cancer cell lines and normal oral cells.
  • To identify structural features that enhance tumor-specificity.

Main Methods:

  • Cytotoxicity was assessed using the MTT assay against human oral squamous cell carcinoma lines and normal oral cells.
  • Tumor-specificity (TS) was calculated as the ratio of CC50 values for normal cells versus tumor cells.
  • Physicochemical, structural, and quantum-chemical parameters were computed using the LowModeMD method.

Main Results:

  • Derivatives with a 7-methoxy group and a 4'-hydroxyl or methoxy group exhibited high TS, outperforming doxorubicin and 5-fluorouracil.
  • QSAR analysis indicated that 3D-MoRSE descriptors and Edge adjacency indices correlated well with tumor-specificity.
  • Adding a hydroxyl group at the 3'-position of the benzene ring significantly increased tumor-specificity.

Conclusions:

  • Molecular shape, size, and polarization are important indicators for assessing the tumor-specificity of 3-benzylidenechromanone derivatives.
  • These findings can guide the design of novel anticancer agents with improved tumor-targeting capabilities.

Related Concept Videos

Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
4.0K
Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:29

Indirect-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Indirect-acting cholinergic agonists are agents that interact with the acetylcholinesterase enzyme in the synaptic cleft, preventing the breakdown of acetylcholine into choline and acetate. Consequently, the concentration of acetylcholine in the synaptic cleft increases. These agonists can be classified into reversible and irreversible inhibitors based on their duration of action.
Reversible inhibitors display short to medium durations of action. Short-acting agents include simple alcohols with...
1.1K
Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship01:22

Direct-Acting Cholinergic Agonists: Chemistry and Structure-Activity Relationship

Cholinergic agonists or cholinomimetics mimic the action of acetylcholine to stimulate the parasympathetic nervous system. They are categorized into direct-acting and indirect-acting agents. The direct-acting cholinergic drugs induce the parasympathetic response by directly binding to the muscarinic or nicotine receptors. In comparison, the indirect-acting cholinergic drugs prevent acetylcholine hydrolysis, indirectly contributing to the extended parasympathetic response.
The direct-acting...
2.4K
Cholinergic Antagonists: Chemistry and Structure-Activity Relationship01:29

Cholinergic Antagonists: Chemistry and Structure-Activity Relationship

Cholinergic antagonists bind to cholinergic receptors and limit the effects of acetylcholine and other cholinergic agonists. Based on the specific cholinergic receptor affinity, these antagonists are classified as muscarinic or nicotinic. Anticholinergics interrupt parasympathetic innervations while sympathetic innervations remain uninterrupted. Muscarinic antagonists are also called 'muscarinic antagonists', 'antimuscarinics', or 'parasympatholytics'. Nicotinic...
3.0K
Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.9K
Prochirality02:05

Prochirality

The concept of prochirality leads to the nomenclature of the individual faces of a molecule and plays a crucial role in the enantioselective reaction. It is a concept where two or more achiral molecules react to produce chiral products. A typical process is the reaction of an achiral ketone to generate a chiral alcohol. Here, the achiral reactant reacts with an achiral reducing agent, sodium borohydride, to generate an equimolar mixture of the chiral enantiomers of the product. For example, an...
5.3K